Oruka Therapeutics (ORKA) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.46
-1.11
-0.75
-0.4

Details

Expected EPS
-0.4901
Actual EPS
-0.46
Surprise EPS
0.03
Surprise Percent
+6.14%

Description

Oruka Therapeutics (ORKA) has reported earnings of -0.46 per share for Q3 2025.

0 Comments

Share your thoughts